Valeant (VRX) Stock Falls as Ackman Trims Stake to 8.5%
NEW YORK (TheStreet) -- Valeant Pharmaceuticals (VRX - Get Report) stock is slumping by 3.25% to $98.35 in afternoon trading on Monday after activist investor Bill Ackman's Pershing Square Capital Management lowered its stake in the specialty ...
Valeant CEO Pearson on medical leave, company being run by 3-man exec group
Communications lessons learned from shareholder activism
Biotech Warriors in Hot Glance: Chimerix, Inc. (NASDAQ:CMRX), Valeant ...